SCHEMBL6045689

SCHEMBL6045689

Nc1ccccc1C1CCN(Cc2ccccc2)CC1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.62
KMT2A Q03164 3/20 0.62
ACHE P22303 4/20 0.56
CCR3 P51677 1/20 0.54
SIGMAR1 Q99720 1/20 0.53
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC7 Q8WUI4 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC10 Q969S8 1/20 0.52
HDAC11 Q96DB2 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
HDAC9 Q9UKV0 1/20 0.52
HDAC5 Q9UQL6 1/20 0.52
DRD2 P14416 4/20 0.51
DRD4 P21917 3/20 0.51
DRD3 P35462 3/20 0.51
BCHE P06276 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4896785 0.92 MEN1 (0.54) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL4896796 0.92 MEN1 (0.54) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL7583523 0.89 MEN1 (0.58) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL13450177 0.81 MEN1 (0.67) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL31328434 0.80 DRD4 (0.47) MEN1KMT2ASIGMAR1DRD2DRD4
SCHEMBL31328423 0.80 DRD4 (0.47) MEN1KMT2ASIGMAR1DRD2DRD4
SCHEMBL20696253 0.80 KDM4E (0.60) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL28425145 0.78 DRD2 (0.65) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL13462879 0.78 MEN1 (0.63) MEN1KMT2AACHECCR3SIGMAR1
SCHEMBL30839566 0.78 MEN1 (0.56) MEN1KMT2ASIGMAR1DRD2OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060252797-A1 Receptor regulator TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-11-09 US disclosed
EP-1559428-A1 RECEPTOR REGULATOR Takeda Pharmaceutical Company Limited (JP) 2005-08-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060252797-A1 Receptor regulator NMUR1, NMUR2, NMBR MEN1 215/4885KMT2A 2790/4885ACHE 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.